These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36864161)

  • 1. P-selectin-targeted nanocarriers induce active crossing of the blood-brain barrier via caveolin-1-dependent transcytosis.
    Tylawsky DE; Kiguchi H; Vaynshteyn J; Gerwin J; Shah J; Islam T; Boyer JA; Boué DR; Snuderl M; Greenblatt MB; Shamay Y; Raju GP; Heller DA
    Nat Mater; 2023 Mar; 22(3):391-399. PubMed ID: 36864161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis.
    Li Y; Song Q; Day BW
    Acta Neuropathol Commun; 2019 Jul; 7(1):123. PubMed ID: 31362788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity.
    Hwang D; Dismuke T; Tikunov A; Rosen EP; Kagel JR; Ramsey JD; Lim C; Zamboni W; Kabanov AV; Gershon TR; Sokolsky-Papkov PhD M
    Nanomedicine; 2021 Feb; 32():102345. PubMed ID: 33259959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma.
    Kim J; Dey A; Malhotra A; Liu J; Ahn SI; Sei YJ; Kenney AM; MacDonald TJ; Kim Y
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24205-24212. PubMed ID: 32934143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma.
    Bell JB; Rink JS; Eckerdt F; Clymer J; Goldman S; Thaxton CS; Platanias LC
    Sci Rep; 2018 Jan; 8(1):1211. PubMed ID: 29352211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for caveolin-mediated transcytosis in facilitating transport of large cargoes into the brain via ultrasound.
    Pandit R; Koh WK; Sullivan RKP; Palliyaguru T; Parton RG; Götz J
    J Control Release; 2020 Nov; 327():667-675. PubMed ID: 32918963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrier.
    Rohner A; Spilker ME; Lam JL; Pascual B; Bartkowski D; Li QJ; Yang AH; Stevens G; Xu M; Wells PA; Planken S; Nair S; Sun S
    Mol Cancer Ther; 2012 Jan; 11(1):57-65. PubMed ID: 22084163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
    Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived orthotopic xenograft models of medulloblastoma lack a functional blood-brain barrier.
    Genovesi LA; Puttick S; Millar A; Kojic M; Ji P; Lagendijk AK; Brighi C; Bonder CS; Adolphe C; Wainwright BJ
    Neuro Oncol; 2021 May; 23(5):732-742. PubMed ID: 33258962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-Brain Barrier Breakdown Determines Differential Therapeutic Outcome in Genetically Diverse Forms of Medulloblastoma.
    Guerit S; Liebner S
    Cancer Cell; 2016 Apr; 29(4):427-429. PubMed ID: 27070693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma.
    Infante P; Malfanti A; Quaglio D; Balducci S; De Martin S; Bufalieri F; Mastrotto F; Basili I; Garofalo M; Lospinoso Severini L; Mori M; Manni I; Moretti M; Nicoletti C; Piaggio G; Caliceti P; Botta B; Ghirga F; Salmaso S; Di Marcotullio L
    Cancer Lett; 2021 Feb; 499():220-231. PubMed ID: 33249196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment.
    Tamayo-Orrego L; Charron F
    F1000Res; 2019; 8():. PubMed ID: 31700613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma.
    Gordon RE; Zhang L; Peri S; Kuo YM; Du F; Egleston BL; Ng JMY; Andrews AJ; Astsaturov I; Curran T; Yang ZJ
    Clin Cancer Res; 2018 Mar; 24(6):1375-1388. PubMed ID: 29437795
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered blood-brain barrier transport of nanotherapeutics in lysosomal storage diseases.
    Solomon M; Loeck M; Silva-Abreu M; Moscoso R; Bautista R; Vigo M; Muro S
    J Control Release; 2022 Sep; 349():1031-1044. PubMed ID: 35901858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHH inhibitors for the treatment of medulloblastoma.
    Samkari A; White J; Packer R
    Expert Rev Neurother; 2015; 15(7):763-70. PubMed ID: 26027634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma.
    Pak E; MacKenzie EL; Zhao X; Pazyra-Murphy MF; Park PMC; Wu L; Shaw DL; Addleson EC; Cayer SS; Lopez BG; Agar NYR; Rubin LL; Qi J; Merk DJ; Segal RA
    Neuro Oncol; 2019 Sep; 21(9):1150-1163. PubMed ID: 31111916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog regulates cerebellar progenitor cell and medulloblastoma apoptosis.
    Noguchi KK; Cabrera OH; Swiney BS; Salinas-Contreras P; Smith JK; Farber NB
    Neurobiol Dis; 2015 Nov; 83():35-43. PubMed ID: 26319366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged response to vismodegib in a patient with systemic medulloblastoma metastases.
    Climans SA; Macdonald DR; Sutherland DE; Mason WP
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33122230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL.
    Linden JR; Flores C; Schmidt EF; Uzal FA; Michel AO; Valenzuela M; Dobrow S; Vartanian T
    PLoS Pathog; 2019 Nov; 15(11):e1008014. PubMed ID: 31703116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study.
    Gajjar A; Stewart CF; Ellison DW; Kaste S; Kun LE; Packer RJ; Goldman S; Chintagumpala M; Wallace D; Takebe N; Boyett JM; Gilbertson RJ; Curran T
    Clin Cancer Res; 2013 Nov; 19(22):6305-12. PubMed ID: 24077351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.